-
Study aim
-
evaluate the effect of Valsalva maneuver on ventricular systolic and diastolic functions, and measurement of NT-proBNP as a marker of heart failure
-
Design
-
patients will be enrolled in two groups:
group 1: patients with mild coronary artery disease
group 2: patients with severe coronary artery disease
-
Settings and conduct
-
Study will be conducted in 3 hospitals affiliated to Shiraz University of Medical Sciences:Faghihi Hospital, Nemazi hospital, and Alzahra Hospital. Serum NT-proBNP level of all patients measured at first 4 hours hospital admission period. Studies conducted during the second phase of Valsalva maneuver. Patients are blown on a narrow serum tube attached to the mercuric barometric device to 40 mm Hg pressure for 10 seconds. Systolic and diastolic indicators once before Valsalva and once during stage 2 of maneuver are measured
-
Participants/Inclusion and exclusion criteria
-
inclusion criteria:male or female, more than 18 years old, diagnosed with acute coronory syndrom, able to co-operate valsalva maneuver, unstable angina, STEMI, N-STEMI
exclusion criteria: previous heart failure, history of several myocardial infarction, need emergency PCI or CABG, chronic respiratory distree or asthma,Persistent ischemia
-
Intervention groups
-
patients diagnosed with possible primary Acute Coronary Syndrome (ACS); unstable angina pectoris, STEMI and NSTEMI
-
Main outcome variables
-
The left atrium end-systolic volume ؛The left atrium volume index; The right atrium end-systolic area; The right ventricle end-systolic and -diastolic dimensions, The left ventricle (LV) ejection fraction; The peak flow velocity in early diastole (E-wave) and during the atrial contraction (A-wave) as well as the E/A ratio; Left and right ventricular systolic function; and serum NT-proBNP level willbe measured at first 4 hours hospital admission period in and its relation with echcardiographic changes will be studied